Everly Bio
PrivateLast Round
Accelerator
Jan 1, 2023
Company Overview
Everly Bio operates in Enterprise Software and is based in Jerusalem. Its latest recorded funding round was an Accelerator round in January 2023.
Everly Bio is a biotechnology company that operates a computational biology process using an AI-driven, non-invasive approach for decision-support in fertility care.
Sector
Enterprise Software
Verticals
Workflow Automation, NLP & Conversational AI, Vertical SaaS, CRM, Customer Experience
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Everly Bio Comparables
Compare Everly Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carly AI | 80% | |
| Lindy | 78% | |
| alfred_ | 70% |
For institutional investors. Book with your work email.
Everly Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Everly Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yissum Research Development Company of the Hebrew University of Jerusalem | Accelerator |
| VLX Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2023
Led by VLX Ventures with participation from Yissum.
For institutional investors. Book with your work email.
Everly Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Everly Bio's valuation, stock price, and market status.
Is Everly Bio a public or private company?
Everly Bio is a private company.
What is the current stock price of Everly Bio?
Everly Bio is a private company, so its shares have no public market price. Caplight tracks Everly Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Everly Bio worth (valuation)?
Valuation information for Everly Bio is not publicly available.
Can I buy Everly Bio stock?
Everly Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Everly Bio's last funding round?
Everly Bio's most recent funding round was Accelerator on January 1, 2023.
Who are the main investors in Everly Bio?
Key investors in Everly Bio include VLX Ventures.
Will Everly Bio IPO soon?
No public IPO plans have been announced for Everly Bio.
How can I track Everly Bio secondary market activity?
Caplight tracks bids, offers, and trades in Everly Bio's shares on secondary markets.